EvergreenHealth is an integrated two-hospital healthcare system offering a breadth of services and programs that is among the most comprehensive in this Pacific Northwest region. It was founded in 1972 and now serves nearly 850,000 residents in the north King and south Snohomish counties. They have nearly 3,000 staff, 950 physician partners and nearly 1,100 volunteers. Their Evergreen Medical Group includes nearly a 300-physician member physician multispecialty group including 13 primary care centers. The Monroe Monitor Valley News reports that Evergreen is currently recruiting for a research study on an innovative, non-invasive treatment for Essential Tumor (ET) beginning in January 2019. This represents Evergreen’s second ET study.
Sponsored by Cala Health, a medical technology company, it is designed to relieve hand tremors using noninvasive electrical stimulation for patients living with the effects of ET. Essential Tremor is a movement disorder that affects more than 7 million Americans.
Who is Cala Health? Formed in 2014 and based in the San Francisco Bay Area, they are a medical technology company pioneering a new class of electrical medicine called neuroperipheral therapy. They have raised $21.3 million according to website Crunchbase.com.
Kate Rosenbluth, PhD is a co-founder. She works to translate the latest neuroscience innovations into accessible therapies. She was an Innovation Fellow in Stanford Biodesign, Adjunct Faculty in Stanford Technology Ventures Program and a Postdoctoral Fellow in UCSF Neurosurgery. Rosenbluth has developed cutting-edge neurotherapies with Brainlab, Autonomic Technologies and Genentech. She has apparently authored numerous patents and published over 30 peer-reviewed papers. Having earned a PhD in Bioengineering from UC Berkeley and UCSF, Rosenbluth also achieved her BS in Mechanical Engineering from Stanford. Cala Health clearly has a highly intelligent, academically pedigreed founding group.
Lead Research/InvestigatorSource: Monroe Monitor